Search Results

Neurotensin (1-11) 2 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide involved in hormone release; NTS agonist.

More Information Supplier Page

×

Neurotensin (1-11)

Neurotensin (1-11) 1 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide involved in hormone release; NTS agonist.

More Information Supplier Page

×

Neurotensin (1-11)

[D-Trp11]-Neurotensin 25 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide involved in hormone release; NTS agonist.

More Information Supplier Page

×

[D-Trp11]-Neurotensin

[D-Trp11]-Neurotensin 10 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous neuropeptide involved in hormone release; NTS agonist.

More Information Supplier Page

×

[D-Trp11]-Neurotensin

RFRP-1, human 1 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, avian GnIG analog; GPR147 activator.

More Information Supplier Page

×

RFRP-1, human

Neuropeptide Y, human/rat 10 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous peptide neurotransmitter, involved in feeding behavior, stress signaling, circadian rhythm; Y1-5 agonist.

More Information Supplier Page

×

Neuropeptide Y, human/rat

Neuropeptide Y, human/rat 5 mg  | ≥95%

LKT Laboratories, Inc.

Endogenous peptide neurotransmitter, involved in feeding behavior, stress signaling, circadian rhythm; Y1-5 agonist.

More Information Supplier Page

×

Neuropeptide Y, human/rat

RGDC 25 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, used to study cell-surface binding; potential integrin inhibitor.

More Information Supplier Page

×

RGDC

RGDC 10 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, used to study cell-surface binding; potential integrin inhibitor.

More Information Supplier Page

×

RGDC

RGDC 5 mg  | ≥95%

LKT Laboratories, Inc.

Peptide, used to study cell-surface binding; potential integrin inhibitor.

More Information Supplier Page

×

RGDC